POLYCYTHEMIA VERA
Clinical trials for POLYCYTHEMIA VERA explained in plain language.
Never miss a new study
Get alerted when new POLYCYTHEMIA VERA trials appear
Sign up with your email to follow new studies for POLYCYTHEMIA VERA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill may help control thick blood disease
Disease control CompletedThis study tested an experimental pill called bomedemstat in 20 people with polycythemia vera, a condition where the body makes too many red blood cells. The goal was to see if the drug could safely lower blood thickness without needing blood removal procedures. Participants took…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE2 • Sponsor: Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) • Aim: Disease control
Last updated May 26, 2026 04:51 UTC
-
New Two-Step transplant shows promise for blood cancer patients
Disease control CompletedThis study tested a two-step stem cell transplant for people with blood cancers like leukemia and lymphoma. The approach uses low-dose chemo and radiation before a donor stem cell infusion, followed by drugs to prevent graft-versus-host disease. The goal was to control the cancer…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 26, 2026 04:33 UTC
-
New hope for myelofibrosis patients after standard treatments fail
Disease control CompletedThis study tested a drug called itacitinib in 4 people with a bone marrow disorder called myelofibrosis. Participants had already taken other drugs (ruxolitinib or fedratinib) that stopped working. The main goals were to check safety and see if the drug could shrink an enlarged s…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 26, 2026 04:33 UTC
-
New combo therapy tested for rare blood cancers
Disease control CompletedThis early-phase study tested a new drug (TGR-1202) combined with a standard drug (ruxolitinib) in 60 people with myelofibrosis or polycythemia vera that stopped responding to usual treatment. The main goal was to check safety and find the right dose. Researchers also looked for …
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New Two-Step transplant shows promise for tough blood cancers
Disease control CompletedThis study tested a two-step stem cell transplant for people with high-risk blood cancers like leukemia and lymphoma. First, patients got low-dose chemotherapy and radiation to prepare the body. Then, they received donor immune cells followed by donor stem cells to help destroy c…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Drug dasatinib shows promise for rare blood cancers
Disease control CompletedThis study tested the drug dasatinib in 68 adults with several blood and bone marrow disorders, including certain leukemias, myelofibrosis, and mastocytosis. The goal was to see if dasatinib could help control these diseases and to check its safety. Results focused on how many pa…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 18, 2026 11:59 UTC